Medizone International Inc (MZEI) financial statements (2022 and earlier)

Company profile

Business Address 350 EAST MICHIGAN AVENUE
KALAMAZOO, MI 49007
State of Incorp. NV
Fiscal Year End December 31
SIC 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments306159233983749
Cash and cash equivalents306159233983749
Inventory, net of allowances, customer advances and progress billings290312241241110106323
Inventory290312241241110106323
Prepaid expense23388592826335
Total current assets:343410385355590206407
Noncurrent Assets
Property, plant and equipment     00
Other noncurrent assets120129135150156157163
Total noncurrent assets:120129135150156157164
TOTAL ASSETS:463539520505745363571
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities638786625539460546434
Accounts payable638662625539460546434
Employee-related liabilities 124     
Debt362368299308297308292
Derivative instruments and hedges, liabilities691701755883985  
Due to related parties7806816175575396041,929
Customer advances and deposits      119
Other liabilities631623599606593587600
Other undisclosed current liabilities1,9091,7461,8311,8201,8431,843453
Total current liabilities:5,0104,9044,7274,7124,7163,8883,826
Noncurrent Liabilities
Long-term debt and lease obligation  7575757575
Long-term debt, excluding current maturities  7575757575
Total noncurrent liabilities:  7575757575
Total liabilities:5,0104,9044,8024,7874,7913,9633,901
Stockholders' equity
Stockholders' equity attributable to parent(4,547)(4,365)(4,282)(4,282)(4,046)(3,599)(3,331)
Common stock408405400396394374370
Additional paid in capital35,18634,97734,69234,42633,68032,70032,544
Accumulated other comprehensive loss(55)(52)(50)(50)(48)(42)(38)
Accumulated deficit(40,086)(39,694)(39,324)(39,054)(38,072)(36,631)(36,207)
Total stockholders' equity:(4,547)(4,365)(4,282)(4,282)(4,046)(3,599)(3,331)
TOTAL LIABILITIES AND EQUITY:463539520505745363571

Income statement (P&L) ($ in thousands)

12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
Revenues     237 
Cost of revenue    (3)(200) 
Gross profit:    (3)37 
Operating expenses(375)(398)(370)(1,076)(1,386)(653)(312)
Other undisclosed operating income    3200 
Operating loss:(375)(398)(370)(1,076)(1,386)(416)(312)
Nonoperating income
(Investment Income, Nonoperating)
0000000
Interest and debt expense(27)(27)(27)(9)(8)(9)(9)
Net loss:(402)(425)(397)(1,085)(1,394)(425)(321)
Other undisclosed net income (loss) attributable to parent1055127103(47)  
Net loss available to common stockholders, diluted:(392)(370)(270)(982)(1,441)(425)(321)

Comprehensive Income ($ in thousands)

12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
Net loss:(402)(425)(397)(1,085)(1,394)(425)(321)
Comprehensive loss, net of tax, attributable to parent:(402)(425)(397)(1,085)(1,394)(425)(321)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: